Bridging to liver transplantation patients with a hepatocellular carcinoma within Milan criteria: how worth is it?

Affiliations

¹ Division of Gastroenterology and Hepatology, CRC "AM e A Migliavacca" Center for Liver Disease, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy.
² Department of Medicine, Humanitas Clinical and Research Center, Humanitas Hospital, Rozzano, Italy.

Editorial

Angelo Sangiovanni et al. Hepatobiliary Surg Nutr. 2018 Jun.

. 2018 Jun;7(3):202-205.

doi: 10.21037/hbsn.2018.03.12.

¹ Division of Gastroenterology and Hepatology, CRC "AM e A Migliavacca" Center for Liver Disease, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy.
² Department of Medicine, Humanitas Clinical and Research Center, Humanitas Hospital, Rozzano, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW. Agopian VG, et al. Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381. Ann Surg. 2017. PMID: 28654545

1. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67:358-80. 10.1002/hep.29086 - DOI - PubMed
1. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43. 10.1016/j.jhep.2011.12.001 - DOI - PubMed
1. Mazzaferro V. Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. Hepatology 2016;63:1707-17. 10.1002/hep.28420 - DOI - PMC - PubMed
1. Millonig G, Graziadei IW, Freund MC, et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007;13:272-9. 10.1002/lt.21033 - DOI - PubMed
1. Allard MA, Sebagh M, Ruiz A, et al. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? J Hepatol 2015;63:83-92. 10.1016/j.jhep.2015.01.023 - DOI - PubMed